Special Issue
Cellular and molecular foundations in the management of chronic complications of diabetes mellitus
Submission Deadline: 31 December 2021
Articles: 1
Special Issue Editor
Guest Editor
Ernest A Adeghate
MD, PhD, College of Medicine & Health Sciences, United Arab Emirates University
Expertise: 213 publications, 25 grants, Editor of The Open Medicinal Chemistry Journal (Editor in Chief); World Journal of Diabetes; The Open Diabetes Journal; Current Diabetes Reviews; Neuroendocrinology Journal, Orvosi Hetilap
Manuscript Submission Information

Manuscripts should be submitted online at https://jour.ipublishment.com/bri by registering and logging into this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is $500. We normally offer a discount greater than 30% (APC: $350) to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and written in clear, concise English and should contain all essential data in order to make the presentation clear and the results of the study replicable.

Cell Biology, Endocrine System, Molecular Biology, Therapeutics
Share This Special Issue
Published Papers (1 papers)
Open Access

Gut dysbiosis, insulin resistance and Alzheimer’s disease: review of a novel approach to neurodegeneration

Evelyn Lazar, Ayesha Sherzai, Jennifer Adeghate, Dean Sherzai
Frontiers in Bioscience-Scholar Volume 13 Issue 1, pp.17-29
Managing Editor: Ernest A Adeghate
DOI: 10.52586/S550 Published: 30 June 2021